'Healthy' vitamin B12 levels not enough to ward off neuro decline: Experts call for new recommendations for older

Updated on: April 28,2025

'Healthy' vitamin B12 levels not enough to ward off neuro decline: Experts call for new recommendations for older

Updated on:April 28,2025

Biogen reanalyzes studies, presses ahead on Alzheimer's drug

by Marilynn MarchioneIn this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal ap

Updated on: April 25,2024

Biogen reanalyzes studies, presses ahead on Alzheimer's drug

by Marilynn MarchioneIn this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal ap

Updated on:April 25,2024

Unlocking Alzheimer's mysteries: A comprehensive brain connectome-based survey

by TranSpreadStructural connectivity (SC) refers to anatomical links and is usually estimated using fiber bundles derived from diffusion MRI; Functional connectivity (FC) and effective connectivity (E

Updated on: March 28,2024

Unlocking Alzheimer's mysteries: A comprehensive brain connectome-based survey

by TranSpreadStructural connectivity (SC) refers to anatomical links and is usually estimated using fiber bundles derived from diffusion MRI; Functional connectivity (FC) and effective connectivity (E

Updated on:March 28,2024

HBOT showed improvement in Alzheimer's disease

by Louisiana State UniversityCredit: Louisiana State UniversityDr. Paul Harch, Clinical Professor and Director of Hyperbaric Medicine at LSU Health New Orleans School of Medicine, and Dr. Edward

Updated on: March 30,2024

HBOT showed improvement in Alzheimer's disease

by Louisiana State UniversityCredit: Louisiana State UniversityDr. Paul Harch, Clinical Professor and Director of Hyperbaric Medicine at LSU Health New Orleans School of Medicine, and Dr. Edward

Updated on:March 30,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on: June 20,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on:June 20,2024

Effects of type 2 diabetes are major risk to development of Alzheimer's disease

by Osaka City UniversityIncreased levels of blood glucose (green) after food intake trigger insulin (blue) secretion from islet β cells. This glucose-triggered insulin secretion is accompanied wi

Updated on: March 13,2024

Effects of type 2 diabetes are major risk to development of Alzheimer's disease

by Osaka City UniversityIncreased levels of blood glucose (green) after food intake trigger insulin (blue) secretion from islet β cells. This glucose-triggered insulin secretion is accompanied wi

Updated on:March 13,2024

New synapse type discovered through spatial proteomics

by Tamara Bäßler,Max Planck SocietyNeuronal atlas with 30 different protein types in spatial resolution, visualized with the new SUM-PAINT method. The detailed images illustrate the extremely hi

Updated on: March 30,2024

New synapse type discovered through spatial proteomics

by Tamara Bäßler,Max Planck SocietyNeuronal atlas with 30 different protein types in spatial resolution, visualized with the new SUM-PAINT method. The detailed images illustrate the extremely hi

Updated on:March 30,2024

Preliminary study: Drug may be safe in those with mild cognitive impairment, mild dementia

by American Academy of NeurologyCredit: CC0 Public DomainA small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Al

Updated on: February 05,2024

Preliminary study: Drug may be safe in those with mild cognitive impairment, mild dementia

by American Academy of NeurologyCredit: CC0 Public DomainA small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Al

Updated on:February 05,2024

Artificial intelligence predicts dementia before onset of symptoms

by McGill UniversityCredit: McGill UniversityImagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and the

Updated on: March 09,2024

Artificial intelligence predicts dementia before onset of symptoms

by McGill UniversityCredit: McGill UniversityImagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and the

Updated on:March 09,2024

Untangling the role of tau in Alzheimer's disease

by Dani Ellenby, Okinawa Institute of Science and Technology Graduate UniversityWild-type (WT) h-tau loaded in presynaptic terminals inhibited excitatory synaptic transmission. Credit: Tetsuya Hori et

Updated on: July 01,2024

Untangling the role of tau in Alzheimer's disease

by Dani Ellenby, Okinawa Institute of Science and Technology Graduate UniversityWild-type (WT) h-tau loaded in presynaptic terminals inhibited excitatory synaptic transmission. Credit: Tetsuya Hori et

Updated on:July 01,2024

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a

Updated on: March 07,2024

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a

Updated on:March 07,2024

Researchers create a new window on leading genetic cause of Alzheimer's

by Pacific Northwest National LaboratoryWorkflow for molecular characterization of CSF-Lps.Lipoproteins are exchange labeled with a rhodamine-containing phospholipid and size distribution determi

Updated on: March 02,2024

Researchers create a new window on leading genetic cause of Alzheimer's

by Pacific Northwest National LaboratoryWorkflow for molecular characterization of CSF-Lps.Lipoproteins are exchange labeled with a rhodamine-containing phospholipid and size distribution determi

Updated on:March 02,2024